AbbVie(NYSE:ABBV) reported Q1 adjusted earnings of $2.46 per diluted share, compared with $3.16 a year earlier.
Analysts polled by Capital IQ expected $2.48.
Net revenue for the quarter ended March 31 was $12.23 billion, compared with $13.54 billion a year earlier.
Analysts surveyed by Capital IQ expected $12.25 billion.
The company raised its adjusted earnings guidance for full-year 2023 to $10.72 to $11.12 per diluted share from $10.62 to $11.02.
Analysts polled by Capital IQ expect 2023 adjusted earnings of $10.95.